Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2630

Apr 4, 2016

On-Demand Drug Production Is on the Horizon

Posted by in category: biotech/medical

I see both positive and many negatives to this. Anything available to pharmacies, etc. is also retrievable by cartels.


A continuous-flow method to synthesize medicine promises to change how pharmaceuticals are produced and used.

By Bob Roehr on April 1, 2016.

Continue reading “On-Demand Drug Production Is on the Horizon” »

Apr 2, 2016

Of mice and old men: is the elixir of youth finally coming of age?

Posted by in categories: bioengineering, biotech/medical, genetics, life extension, neuroscience

Preliminary work suggests that T-cells, which normally target disease, can be genetically engineered to target senescent cells in a wide range of tissues. In future, an infusion of GM blood every few years might be able to keep you going indefinitely (assuming some major advances in treating cancer, Alzheimer’s and heart disease). At which point, the question might be less: “How long have I got?” and more: “How long do you fancy sticking around?”


American scientists have coined the term ‘senolytics’ to describe a new class of drugs designed to delay the ageing process by clearing out doddery cells.

Read more

Apr 2, 2016

Europe gives green light to first gene therapy for children

Posted by in categories: biotech/medical, genetics

LONDON The world’s first life-saving gene therapy for children, developed by Italian scientists and GlaxoSmithKline, has been recommended for approval in Europe, boosting the pioneering technology to fix faulty genes.

The European Medicines Agency (EMA) said on Friday it had endorsed the therapy, called Strimvelis, for a tiny number of children with ADA Severe Combined Immune Deficiency (ADA-SCID) for whom no matching bone marrow donor is available.

Around 15 children a year are born in Europe with the ultra-rare genetic disorder, which leaves them unable to make a type of white blood cell. They rarely survive beyond two years unless their immune function is restored with a suitable bone marrow transplant.

Read more

Apr 1, 2016

A programming language for living cells

Posted by in categories: biotech/medical, computing, engineering

MIT biological engineers have created a programming language that allows them to rapidly design complex, DNA-encoded circuits that give new functions to living cells.

Using this language, anyone can write a program for the function they want, such as detecting and responding to certain . They can then generate a DNA sequence that will achieve it.

“It is literally a for bacteria,” says Christopher Voigt, an MIT professor of biological engineering. “You use a text-based language, just like you’re programming a computer. Then you take that text and you compile it and it turns it into a DNA sequence that you put into the cell, and the circuit runs inside the cell.”

Read more

Mar 31, 2016

On/off button for passing along epigenetic ‘memories’ to our children discovered

Posted by in categories: biotech/medical, genetics

The duration of epigenetic responses underpinning transgenerational inheritance is determined by an active mechanism relying on the production of small RNAs and modulation of RNAi factors, dictating whether ancestral RNAi responses would be memorized or forgotten (credit: Leah Houri-Ze’evi et al./Cell)

According to epigenetics — the study of inheritable changes in gene expression not directly coded in our DNA — our life experiences may be passed on to our children and our children’s children. Studies on survivors of traumatic events have suggested that exposure to stress may indeed have lasting effects on subsequent generations.

But exactly how are these genetic “memories” passed on?

Continue reading “On/off button for passing along epigenetic ‘memories’ to our children discovered” »

Mar 31, 2016

Microneedle Patch Delivers Localized Cancer Immunotherapy to Melanoma

Posted by in categories: biotech/medical, engineering

Biomedical engineering researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a technique that uses a patch embedded with microneedles to deliver cancer immunotherapy treatment directly to the site of melanoma skin cancer. In animal studies, the technique more effectively targeted melanoma than other immunotherapy treatments.

According to the CDC, more than 67,000 people in the United States were diagnosed with melanoma in 2012 alone – the most recent year for which data are available. If caught early, melanoma patients have a 5-year survival rate of more than 98 percent, according to the National Cancer Institute. That number dips to 16.6 percent if the cancer has metastasized before diagnosis and treatment. Melanoma treatments range from surgery to chemotherapy and radiation therapy. A promising new field of cancer treatment is cancer immunotherapy, which helps the body’s own immune system fight off cancer.

Read more

Mar 30, 2016

This Week in Science: Mar 20 — 27, 2016

Posted by in categories: 3D printing, bioengineering, biotech/medical, science, space

3D printed heart replicas, A new type of colossal galaxy, shutting down HIV with gene editing, and more!

Read more

Mar 30, 2016

This Week in Science: March 20-27th 2016

Posted by in categories: 3D printing, bioengineering, biotech/medical, science, space

This Week in Science — March 20 −27, 2016.


3D printed heart replicas, A new type of colossal galaxy, shutting down HIV with gene editing, and more.

Read more

Mar 29, 2016

WIRB-Copernicus Group Establishes WCG Gene Therapy Advisory Board

Posted by in categories: bioengineering, biotech/medical, genetics, health

1st of many steps in the gene editing oversight.


PRINCETON, N.J., March 29, 2016 /PRNewswire/ — WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that it has assembled a team of world-renowned experts to advise the company regarding the latest advances in gene therapy research. The WCG Gene Therapy™ Advisory Board will convene today in Princeton, NJ.

“Human gene therapy is one of the fastest-growing areas of medical research, and also one of the most promising,” said WCG Chairman and Chief Executive Officer Donald A. Deieso, Ph.D. “The advances made by scientists and clinicians in the field of gene therapy have enabled us to target disease at the genetic level, redefining the concept of precision medicine.” He added, “More than that, gene transfer researchers have succeeded – over the course of a single lifetime – in transforming the world’s most persistent and lethal viruses into disease-fighting allies in the quest to improve human health.”

Continue reading “WIRB-Copernicus Group Establishes WCG Gene Therapy Advisory Board” »

Mar 29, 2016

Magic Microbes: The Navy’s Next Defense?

Posted by in categories: bioengineering, biotech/medical, computing, materials, nanotechnology, neuroscience, robotics/AI

Synthetic biology involves creating or re-engineering microbes or other organisms to perform specific tasks, like fighting obesity, monitoring chemical threats or creating biofuels. Essentially, biologists program single-celled organisms like bacteria and yeast much the same way one would program and control a robot.

But 10 years ago, it was extremely challenging to take a DNA sequence designed on a computer and turn it into a polymer that could implement its task in a specific host, say a mouse or human cell. Now, thanks to a multitude of innovations across computing, engineering, biology and other fields, researchers can type out any DNA sequence they want, email it to a synthesis company, and receive their completed DNA construct in a week. You can build entire chromosomes and entire genomes of bacteria in this way.

Continue reading “Magic Microbes: The Navy’s Next Defense?” »